Trademark: 88115622
Status Date
Tuesday, May 19, 2020
Registration Number
6059503
Registration Date
Tuesday, May 19, 2020
Filing Date
Thursday, September 13, 2018
Published for Opposition
Tuesday, August 27, 2019
5 Pharmaceutical and over the counter preparations directed to oxidative stress, cellular damage, and inflammation, intended for the treatment and prevention of cardiovascular conditions, arthritis, diabetes, osteoporosis, dementia and Alzheimer's disease, and for optimization of endurance and exercise recovery and oral health, and excluding wound dressings and treatments for wound care; veterinary pharmaceutical and over the counter preparations directed to oxidative stress, cellular damage, and inflammation intended for the treatment and prevention of cardiovascular conditions, arthritis, diabetes, osteoporosis, and dementia, and for optimization of exercise recovery and oral health, and excluding wound dressings and treatments for wound care
May 19, 2020
Registered-Principal Register
Apr 14, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Apr 13, 2020
Allowed Principal Register - Sou Accepted
Mar 20, 2020
Statement Of Use Processing Complete
Mar 3, 2020
Use Amendment Filed
Mar 20, 2020
Case Assigned To Intent To Use Paralegal
Mar 3, 2020
Teas Statement Of Use Received
Oct 22, 2019
Noa E-Mailed - Sou Required From Applicant
Aug 27, 2019
Official Gazette Publication Confirmation E-Mailed
Aug 27, 2019
Published For Opposition
Aug 7, 2019
Notification Of Notice Of Publication E-Mailed
Jul 21, 2019
Assigned To Lie
Jul 10, 2019
Approved For Pub - Principal Register
Jul 3, 2019
Teas/Email Correspondence Entered
Jul 2, 2019
Correspondence Received In Law Office
Jul 2, 2019
Teas Response To Office Action Received
Jan 2, 2019
Notification Of Non-Final Action E-Mailed
Jan 2, 2019
Non-Final Action E-Mailed
Jan 2, 2019
Non-Final Action Written
Dec 26, 2018
Assigned To Examiner
Sep 20, 2018
New Application Office Supplied Data Entered In Tram
Sep 17, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
